Zhejiang Ausun Pharmaceutical Co Ltd Cash Flow-to-Debt Ratio
Zhejiang Ausun Pharmaceutical Co Ltd cash flow-to-debt ratio. Zhejiang Ausun Pharmaceutical Co Ltd (603229) has a Cash Flow-to-Debt Ratio of 0.17x as of September 2025, meaning its operating cash flow of CN¥121.49 Million could theoretically repay 0% of its total liabilities (CN¥713.05 Million) in one year. Check earnings quality score of Zhejiang Ausun Pharmaceutical Co Ltd to evaluate the quality of earnings relative to operating cash generation.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Cash Flow-to-Debt Ratio of Zhejiang Ausun Pharmaceutical Co Ltd (2012–2025)
Cash flow-to-debt ratio of Zhejiang Ausun Pharmaceutical Co Ltd from 2012 to 2025. Historical debt coverage capacity for Zhejiang Ausun Pharmaceutical Co Ltd across 14 annual periods. Check 603229 total capital reinvestment ratio to assess the company's total reinvestment commitment from operating cash flow.
Zhejiang Ausun Pharmaceutical Co Ltd Cash Flow-to-Debt Ratio by Year (2012–2025)
Zhejiang Ausun Pharmaceutical Co Ltd cash flow-to-debt ratio by year from 2012 to 2025. Year-by-year debt coverage analysis for Zhejiang Ausun Pharmaceutical Co Ltd. For the full cash flow conversion analysis, see Zhejiang Ausun Pharmaceutical Co Ltd cash conversion from operations.
| Year | CF-to-Debt Ratio | Operating CF (CNY) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2025 | 0.19x | CN¥156.51 Million | CN¥815.89 Million | ▼ -23.4% |
| 2024 | 0.25x | CN¥177.93 Million | CN¥710.50 Million | ▼ -8.6% |
| 2023 | 0.27x | CN¥221.85 Million | CN¥809.99 Million | ▲ +94.0% |
| 2022 | 0.14x | CN¥120.57 Million | CN¥854.19 Million | ▼ -52.5% |
| 2021 | 0.30x | CN¥173.90 Million | CN¥584.64 Million | ▼ -45.3% |
| 2020 | 0.54x | CN¥138.47 Million | CN¥254.81 Million | ▲ +49.3% |
| 2019 | 0.36x | CN¥87.73 Million | CN¥240.96 Million | ▲ +546.9% |
| 2018 | 0.06x | CN¥11.50 Million | CN¥204.38 Million | ▼ -78.7% |
| 2017 | 0.26x | CN¥46.78 Million | CN¥176.65 Million | ▼ -42.4% |
| 2016 | 0.46x | CN¥93.21 Million | CN¥202.76 Million | ▲ +83.3% |
| 2015 | 0.25x | CN¥53.63 Million | CN¥213.81 Million | ▲ +112.7% |
| 2014 | 0.12x | CN¥21.45 Million | CN¥181.90 Million | ▲ +9.4% |
| 2013 | 0.11x | CN¥15.73 Million | CN¥145.87 Million | ▲ +1163.0% |
| 2012 | -0.01x | CN¥-1.14 Million | CN¥112.21 Million | — |